New Search / Research Home
Inadequate and incomplete: Chinese newspapers’ coverage of the first licensed human papillomavirus (HPV) vaccine in China Michael Cacciatore and Glen Nowak

Abstract: Glaxo Smith Kline’s Cervarix was the first human papillomavirus (HPV) vaccine licensed for use in China in July 2016 and officially launched there on July 31, 2017. Since news media content can influence people’s vaccine-related knowledge, understanding, and intentions, a content analysis was used to examine the information conveyed to the public about the […]

Read More